ArticleCancer biology & therapy2014

Trastuzumab-induced recruitment of Csk-homologous kinase (CHK) to ErbB2 receptor is associated with ErbB2-Y1248 phosphorylation and ErbB2 degradation to mediate cell growth inhibition.

Milos Dokmanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.